Assessing the Clinical Significance of Monocyte Chemoattractant Protein 1 and Protein Oxidation Products in Patients with Chronic Periodontitis
Iraqi Journal of Pharmaceutical Sciences · 24.06.2026 · 35 (2) · 125-135
DOI: 10.31351/vol35iss2pp125-135 ↗Kurz gefasst
Fachartikel in der Zeitschrift Iraqi Journal of Pharmaceutical Sciences, online erschienen am 24.06.2026. Verfasst von Hazhar M. Balaky und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
An essential chemokine called monocyte chemoattractant protein-1 (MCP-1) is in charge of initiating, controlling, and mobilizing monocytes to the sites of active severe periodontal inflammation. The purpose of the current study is to assess the serum levels of MCP-1 and protein oxidation products in chronic periodontitis patients, namely Advanced Oxidation Protein Products (AOPP), 3-Nitrotyrosine (3-NT), and Protein Carbonyl (PC). Evaluation of potential relationships between MCP-1 levels and the byproducts of protein oxidation. In the current investigation, 45 patients with severe chronic periodontitis (diseased) and 14 healthy individuals took part. Enzyme-linked immunosorbent assay was used to measure the amounts of MCP-1, AOPP, 3-NT, and PC in samples obtained from each participant. Using R statistical software, tests of correlation and linear regression were carried out. Serum levels of MCP-1, AOPP, 3-NT, and PC were considerably greater in the periodontitis group than in the control group among those with periodontitis. Protein oxidation metrics and MCP-1 exhibited a positive connection. It is indicated that elevated levels of MCP-1, AOPP, 3-NT, and PC could be a possible biomarker for periodontal disorders and that these levels may play a significant role during periodontal inflammation.
Zitieren
APA
Balaky, H. M., & Ismail, P. A. (2026). Assessing the Clinical Significance of Monocyte Chemoattractant Protein 1 and Protein Oxidation Products in Patients with Chronic Periodontitis. Iraqi Journal of Pharmaceutical Sciences, 35(2), 125-135. https://doi.org/10.31351/vol35iss2pp125-135
Vancouver
Balaky HM, Ismail PA. Assessing the Clinical Significance of Monocyte Chemoattractant Protein 1 and Protein Oxidation Products in Patients with Chronic Periodontitis. Iraqi Journal of Pharmaceutical Sciences. 2026;35(2):125-135. doi:10.31351/vol35iss2pp125-135
BibTeX
@article{Balaky2026,
author = {Balaky, Hazhar M. and Ismail, Parween Abdulsamad},
title = {Assessing the Clinical Significance of Monocyte Chemoattractant Protein 1 and Protein Oxidation Products in Patients with Chronic Periodontitis},
journal = {Iraqi Journal of Pharmaceutical Sciences},
year = {2026},
volume = {35},
number = {2},
pages = {125--135},
doi = {10.31351/vol35iss2pp125-135}
}
EUVIMED